Clinical Trials at The University of Texas Health Science Center at Houston
As of August 2026, 133 paid clinical trials are recruiting at The University of Texas Health Science Center at Houston, located at 7500 CAMBRIDGE ST STE 3410, HOUSTON, TX 77054-2032, phone (713) 500-8220 in Houston, Texas. Active studies at this site cover conditions such as Breast Cancer, Acute Myeloid Leukemia and Advanced Solid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Houston
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Disseminating Effective Sexual Health Programs in Schools Using iCHAMPSS
135 clinical trials at The University of Texas Health Science Center at Houston
·Clear filters·A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
PARTNER 3 Trial - Aortic Valve-in-Valve
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
ATLAS (AltaValve) Pivotal Trial
Onyx™ Liquid Embolic IDE Clinical Study
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Clinical Outcome Measure at Stryker Spine
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
US Post-Market Surveillance Study of the Surfacer System
APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study
Contingency Management Plus Deep Transcranial Magnetic Stimulation for the Treatment of Cocaine Use Disorder
Non-Invasive Deep Brain Neuromodulation for Smoking Cessation
Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury
Incretin Microdosing for Cardiometabolic Health in People With HIV
Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Lipid Infusions to Optimize Nutrition Trial
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
Common conditions studied in Houston
- Breast Cancer (79 active studies)
- Acute Myeloid Leukemia (54 active studies)
- Advanced Solid Tumor (53 active studies)
- Ovarian Cancer (47 active studies)
- Colorectal Cancer (45 active studies)
- Prostate Cancer (43 active studies)
Leading research sponsors in Houston
- M.D. Anderson Cancer Center
- The University of Texas Health Science Center, Houston
- Baylor College of Medicine
- AstraZeneca
- The Methodist Hospital Research Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Houston?
There are approximately 3,038 recruiting clinical trials in Houston, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Houston pay participants?
Most recruiting trials in Houston compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Houston?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Houston?
The most common conditions under active study in Houston include Breast Cancer (79), Acute Myeloid Leukemia (54), Advanced Solid Tumor (53), Ovarian Cancer (47), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Houston?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Houston on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Houston?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Houston?
Recruiting research sites in Houston include MD Anderson Cancer Center, M D Anderson Cancer Center, Baylor College of Medicine, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Houston right now?
The largest active categories in Houston are Cancer & tumors (1,191), Neurology & pain (145), Diabetes & metabolic (103). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of The University of Texas Health Science Center at Houston?
The University of Texas Health Science Center at Houston is located at 7500 CAMBRIDGE ST STE 3410, HOUSTON, TX 77054-2032. Use the Google Maps link in the intro above to get directions.
How do I contact The University of Texas Health Science Center at Houston?
You can reach The University of Texas Health Science Center at Houston by phone at (713) 500-8220. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.